
Viking Therapeutics Defies Market Woes with Surprising Surge—Here’s Why It Matters
Major stock indices showed slight gains amid ongoing tariff concerns and Federal Reserve discussions. Viking Therapeutics, Inc. saw a significant stock increase of 10.36%, sparked by the potential of its drug candidate VK2735 for weight loss treatment. Despite facing a 44% quarterly